Clinical trials: Male Erectile Dysfunction
Orthopedic Disorder, Neurologic Disorder
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
To determine the safety and efficacy of Amniotic and Umbilical Cord Tissue for the treatment of the following condition categories: Orthopedic, Neurologic, Urologic, Autoimmune, Renal, Cardiac and Pulmonary Conditions.
- Conditions
- Orthopedic Disorder, Neurologic Disorder, Urologic Diseases, Erectile Dysfunction
- Trial name
- NCT03899298
- Testing
- Amniotic and Umbilical Cord Tissue Procedure
- Volunteers
- 5,000 people, healthy volunteers welcome
- Sponsor
- R3 Stem Cell
Erectile Dysfunction, Diabetes Mellitus
BAY38-9456 - Pivotal Trial for Diabetes Patient
The superiority of BAY 38-9456 10 mg and 20 mg regimens to placebo, and of 20 mg to 10 mg was confirmed in patients with diabetes mellitus suffering from erectile dysfunction.
- Trial name
- NCT00678704
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Volunteers
- 790 people
- Sponsor
- Bayer
Erectile Dysfunction Following Radical Prostatectomy
Early Shockwave Therapy for Post-RP ED
This pilot study aims to explore the feasibility, safety and effectiveness of two different extracorporeal shock wave therapy (ESWT) protocols for patients receiving nerve-sparing radical prostatectomy (RP).
- Trial name
- NCT03905057
- Testing
- Dornier Aries 2 (with active applicator)
- Where
- Spain
- Volunteers
- 94 people
- Sponsor
- Dornier MedTech Systems
Erectile Dysfunction
A Bioavailability Study of LY2452473 and Tadalafil
This study compares LY2452473 taken orally as a 5 milligram (mg) capsule at the same time as a 5 mg tadalafil tablet with three different combination tablets (LY900010) of 5 mg LY2452473 and 5 mg tadalafil taken orally.
- Trial name
- NCT01401543
- Testing
- LY2452473, Tadalafil, LY900010
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Erectile Dysfunction
Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
This phase II clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected intracavernously.
- Trial name
- Cellgram-ED (NCT04594850)
- Testing
- Cellgram-ED
- Where
- 4 sites in South Korea
- Volunteers
- 54 people
- Sponsor
- Pharmicell Co., Ltd.
Erectile Dysfunction
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of udenafil, an orally administered selective inhibitor of PDE-5 for the treatment of subjects with erectile dysfunction (ED).
- Trial name
- NCT01065012
- Testing
- Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg
- Where
- 72 sites in United States
- Volunteers
- 1,027 people
- Sponsor
- Warner Chilcott
Erectile Dysfunctions
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.
The purpose of this study is to evaluate the efficacy and safety of W2505.
- Trial name
- NCT07859202
- Testing
- W2505, W2505-P1, W2505-R
- Where
- South Korea
- Volunteers
- 228 people
- Sponsor
- GL Pharm Tech Corporation
Erectile Dysfunction
Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction
Compare once daily vs on demand treatment in men with erectile dysfunction. Treatment of mild to moderate erectile dysfunction with 10 mg vardenafil p.o.
- Trial name
- NCT00786253
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 19 sites in Germany
- Volunteers
- 236 people
- Sponsor
- Bayer
Impotence
Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra
This study will demonstrate if a treatment optimization program has an impact on the satisfaction with Viagra treatment in men with erectile dysfunction
- Trial name
- NCT00159848
- Testing
- Treatment Optimization Program (educational material)
- Volunteers
- 8,000 people
- Sponsor
- Pfizer
Erectile Dysfunction, Metabolic Syndrome
Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
This is a controlled, randomized, multi-center prospective study of vardenafil to determine efficacy on Erectile Dysfunction (ED), tolerability and safety in men with ED and Metabolic Syndrome.
- Trial name
- NCT00738400
- Testing
- Vardenafil (Levitra, BAY38-9456)
- Where
- 19 sites in Germany
- Volunteers
- 150 people
- Sponsor
- Bayer
Erectile Dysfunction
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
Study to investigate the efficacy and safety of vardenafil flexible dose versus placebo in males with erectile dysfunction, and their female partners' sexual quality of life.
- Trial name
- NCT00657033
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 26 sites in United States, Canada
- Volunteers
- 229 people
- Sponsor
- Bayer
Erectile Dysfunction
DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)
The investigators will examine the beneficial impacts of applying of dHACM on the preserved neurovascular bundles (cavernosal nerves) and the prostate bed during robotic assisted laparoscopic prostatectomy.
- Trial name
- NCT02526173
- Testing
- RALP using full nerve sparing technique, dHACM Application
- Where
- United States
- Volunteers
- 230 people
- Sponsor
- MiMedx Group, Inc.
Erectile Dysfunction, Spinal Cord Injury
Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
Assess efficacy of Vardenafil in patients with traumatic spinal cord injury
- Trial name
- LEMDE (NCT00667966)
- Testing
- Vardenafil (Levitra, BAY 38-9456), 10 mg, Vardenafil (Levitra, BAY 38-9456), 20 mg
- Where
- 2 sites in Spain
- Volunteers
- 45 people
- Sponsor
- Bayer
Erectile Dysfunction
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
To demonstrate the efficacy of various doses of MED2005 versus placebo in male patients with clinically diagnosed erectile dysfunction, and to evaluate the long-term efficacy and safety (12 months) of MED2005.
- Trial name
- NCT03813992
- Testing
- MED2005
- Where
- 53 sites in Bulgaria, Czechia and 7 more
- Volunteers
- 1,005 people
- Sponsor
- Futura Medical Developments Ltd.
Erectile Dysfunction
Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine
Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied Products, dosage, and route of administration: Test 1: Yohimbin "Spiegel"® (Desma GmbH, Germany), tablet…
- Trial name
- NCT00975325
- Testing
- Yohimbine
- Where
- Germany
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Walter Ritter GmbH & Co
Erectile Dysfunction
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of TPN171H in men with erectile dysfunction.
- Trial name
- NCT05188989
- Testing
- TPN171H 2.5mg group, TPN171H 5mg group, TPN171H 10mg group
- Where
- 49 sites in China
- Volunteers
- 765 people
- Sponsor
- Vigonvita Life Sciences
Erectile Dysfunction
Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
This study is a randomized, double-blind, placebo-controlled, two-cohort, three-cycle crossover (at least a 5-day cleaning period per cycle), and a multicenter clinical trial design.
- Trial name
- NCT05388825
- Testing
- TPN171H 2.5mg, TPN171H 5mg, TPN171H 10mg
- Where
- 8 sites in China
- Volunteers
- 84 people
- Sponsor
- Vigonvita Life Sciences
Impotence
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction
To determine the onset of action, safety and toleration of different formulations and doses of UK-369,003 in patients with erectile dysfunction.
- Trial name
- NCT00141349
- Testing
- UK-369,003
- Where
- 39 sites in United States
- Volunteers
- 300 people
- Sponsor
- Pfizer
Erectile Dysfunction
A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers
This is a randomized, open-label, single-dose, five-period crossover, relative bioavailability study to evaluate tadalafil gummy 10mg and tadalafil oral tablets 10mg in healthy volunteers
- Trial name
- NCT04762082
- Testing
- Tadalafil 10 MG
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Seattle Gummy Company
Erectile Dysfunction
Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)
The objective of the pilot study is to assess the feasibility of a full randomised, placebo-controlled clinical trial.The aim is to demonstrate that penile shockwave application in patients with erectile dysfunction of vascular…
- Trial name
- NCT02068417
- Testing
- shock waves
- Where
- Germany
- Volunteers
- 40 people
- Sponsor
- Storz Medical AG